Search

Search Constraints

You searched for: Author/Creator Angiolillo, Dominick J

Search Results

22. Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations. Issue 8 (3rd August 2021)

23. Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week . (4th August 2022)

24. Guided and unguided de-escalation from potent P2Y12 inhibitors among patients with acute coronary syndrome: a meta-analysis. Issue 5 (30th August 2021)

25. Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Issue 10283 (17th April 2021)

26. Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease. Issue 5 (11th June 2021)

27. Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial. Issue 1 (29th October 2020)

28. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Issue 5 (1st September 2016)

29. Impact of residual platelet reactivity on reperfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Issue 5 (September 2016)

30. Institutional profile: University of Florida Health Personalized Medicine Program. (April 2017)